missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 30289503

Choline Acetyltransferase/ChAT Antibody (CL3173) [Biotin], Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-46620B

Product Code. 30289503

  • 770.00 EUR / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Choline Acetyltransferase/ChAT Monoclonal antibody specifically detects Choline Acetyltransferase/ChAT in Human,Mouse,Rat samples. It is validated for Immunohistochemistry,Immunohistochemistry (Paraffin),Immunocytochemistry/ Immunofluorescence
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Choline Acetyltransferase/ChAT
Monoclonal
Biotin
acetyl CoA:choline O-acetyltransferase, ChAT, CHOACTase, Choline acetylase, choline acetyltransferase, choline O-acetyltransferase, CMS1A, CMS1A2, EC 2.3.1, EC 2.3.1.6
This antibody was developed using a recombinant protein derived from P28329, with the exact immunogen sequence remaining proprietary.
0.1 mL
Cellular Markers
1103
Store at 4⪚C in the dark.
IgG2b
Immunohistochemistry, Immunohistochemistry (Paraffin), Immunocytochemistry/Immunofluorescence
CL3173
PBS
Mouse
Protein A purified
RUO
Primary
Human, Mouse, Rat
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.